A Prospective, Single-arm Clinical Study of Liposomal Mitoxantrone Combination Regimen in the Treatment of Relapsed and Refractory Solid Tumors in Children, Adolescents and Young Adults
- Conditions
- Solid TumorsChildrenAdolescents
- Interventions
- First Posted Date
- 2025-01-07
- Last Posted Date
- 2025-01-08
- Target Recruit Count
- 49
- Registration Number
- NCT06761417
- Locations
- 🇨🇳
Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China
Sintilimab Combined With Chemotherapy as Adjuvant Treatment for Phase III GC and GEJ
- Conditions
- Gastric AdenocarcinomaEsophagogastric Junction Adenocarcinoma
- Interventions
- First Posted Date
- 2025-01-07
- Last Posted Date
- 2025-01-07
- Target Recruit Count
- 70
- Registration Number
- NCT06761846
- Locations
- 🇨🇳
Cancer Hodpital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, Beijing, China
Hypofractionated Postoperative Regional Nodal Irradiation for Patients With Intermediate-risk Breast Cancer
- Conditions
- Breast Carcinoma
- First Posted Date
- 2025-01-03
- Last Posted Date
- 2025-01-03
- Target Recruit Count
- 3142
- Registration Number
- NCT06757621
- Locations
- 🇨🇳
National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Beijing, Beijing, China
Quantitative Neurofeedback Techniques for Treating Perioperative Cognitive Disorders in Elderly Patients
- Conditions
- Emergence DeliriumPerioperative Neurocognitive Disorder
- First Posted Date
- 2024-12-30
- Last Posted Date
- 2025-01-08
- Target Recruit Count
- 390
- Registration Number
- NCT06752148
QL1706 Plus Chemotherapy With AG Regime as First-line Treatment of Advanced PDAC
- First Posted Date
- 2024-12-27
- Last Posted Date
- 2025-02-10
- Target Recruit Count
- 30
- Registration Number
- NCT06750861
- Locations
- 🇨🇳
National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, Chaoyang District, China
Neoadjuvant Treatment of Triple-Negative Breast Cancer with Stereotactic Radiotherapy, PD-1 Monoclonal Antibody, and Chemotherapy
- Conditions
- Breast Cancer Invasive
- First Posted Date
- 2024-11-15
- Last Posted Date
- 2025-02-20
- Target Recruit Count
- 20
- Registration Number
- NCT06691594
Sodium Glycididazole Reduces the Adverse Reactions of Concurrent Chemoradiotherapy
- First Posted Date
- 2024-10-31
- Last Posted Date
- 2024-10-31
- Target Recruit Count
- 40
- Registration Number
- NCT06667622
- Locations
- 🇨🇳
Cancer Hospital Chinese Academy of Medical Sciences, Beijing, Beijing, China
The Impact of Inflammatory Adhesion on the Prognosis of Colon Cancer Patients
- Conditions
- Colon Cancer
- First Posted Date
- 2024-10-23
- Last Posted Date
- 2024-11-07
- Target Recruit Count
- 229
- Registration Number
- NCT06655285
- Locations
- 🇨🇳
Cancer Hospital Chinese Academy of Medical Sciences, Beijing, Beijing, China
Prospective Validation and Application of an Artificial Intelligence-based Model for Evaluating the Efficacy of Breast Cancer Patients After Neoadjuvant Therapy
- Conditions
- Breast Cancer
- First Posted Date
- 2024-10-18
- Last Posted Date
- 2024-10-18
- Target Recruit Count
- 300
- Registration Number
- NCT06649565
- Locations
- 🇨🇳
Sanhuan Cancer Hospital, Chaoyang District, Beijing(Cancer Hospital, Chinese Academy of Medical Sciences, close medical alliance), Beijing, Beijing, China
🇨🇳Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, Beijing, China
Right Versus Left Thoracic Surgical Approaches for Siewert II Gastroesophageal Junction Adenocarcinoma
- Conditions
- Siewert Type II Adenocarcinoma of Esophagogastric Junction
- First Posted Date
- 2024-10-16
- Last Posted Date
- 2024-10-16
- Target Recruit Count
- 236
- Registration Number
- NCT06644352
- Locations
- 🇨🇳
Cancer Hospital Chinese Academy of Medical Sciences, Beijing, China